In Vivo Kinetics of Thymidylate Synthetase Inhibition in 5-Fluorouracil-sensitive and -resistant Murine Colon Adenocarcinomas

Cancer Research

Volumn 42, Issue 2, 1982, Pages 450-456

  Spears, C Paul ^a   Shahinian, Antranik H ^a   Moran, Richard G ^a   Heidelberger, Charles ^a   Corbett, Thomas H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYURIDINE PHOSPHATE; FLOXURIDINE PHOSPHATE H 3; FLUOROURACIL; FLUOROURACIL H 3; RADIOISOTOPE; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ARTICLE; COLON CANCER; ENZYME INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; LARGE INTESTINE; MOUSE;

ADENOCARCINOMA; ANIMALS; COLONIC NEOPLASMS; DRUG RESISTANCE; FLUORODEOXYURIDYLATE; FLUOROURACIL; INJECTIONS, INTRAPERITONEAL; KINETICS; METHYLTRANSFERASES; MICE; MICE, INBRED STRAINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RNA; THYMIDYLATE SYNTHASE; TIME FACTORS;

EID: 0020056302     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ansfield, F. J. Chemotherapy of Malignant Neoplasms. Springfield, III.: Charles C Thomas, Publisher, 1973.
2. Ardalan, B., Buscaglia, M. D., and Schein, P. S. Tumor 5-fluoro deoxy uridylate concentration as a determinant of 5-fluorouracil response. Biochem. Pharmacol., 27: 1–5, 1978.
3. Ardalan, B., Cooney, D. A., Jayaram, H. N., Carrico. C. K., Glazer, R. I., MacDonald. J., and Schein, P. S. Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil. Cancer Res., 40: 1431–1437, 1980.
4. Baskin, F., Carlin. S. C., Kraus, P., Friedkin, M., and Rosenberg, R. N. Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma. Mol. Pharmacol., 11: 105–117, 1975.
5. Baugh, C. M., Braverman, E., and Nair, M. G. The identification of poly-γ-glutamyl chain lengths in bacterial folates. Biochemistry, 13: 4952–4957, 1974.
6. Brockman, R.W.T., Shaddix, S. C., and Rose, L. M. Biochemical aspects of chemotherapy of mouse colon carcinoma. Cancer (Phila.), 40: 2681–2691, 1977.
7. Carrico, C. K., and Glazer, R. I. Effect of 5-fluorouracil on the synthesis and translation of polyadenylic acid-containing RNA from regenerating rat liver. Cancer Res., 39: 3694–3701, 1979.
8. Corbett, T. H., Griswold, D. P., Roberts. B. J., Peckham, J. C., and Schabel, F. M. Evaluation of single agents and combinations of chemotherapeutic in mouse colon carcinomas. Cancer (Phila.), 40: 2660–2680, 1977.
9. Cullen, S. I. Topical fluorouracil therapy for precancers and cancers of the skin. J. Am. Geriatr. Soc., 27: 529–535. 1979.
10. Danenberg, P. V. Thymidylate synthetase—a target enzyme in cancer chemotherapy. Biochim. Biophys. Acta, 473: 73–92, 1977.
11. Danenberg, P. V., and Danenberg, K. D. Effect of 5,10-methylenetetrahydrofolate on the dissociation of 5-fluoro-2‘-deoxyuridylate from thymidylate synthetase: evidence for an ordered mechanism. Biochemistry, 17: 4018–4024, 1978.
12. Evans. R. M., Laskin, J. D., and Hakala, M. T. Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells. Cancer Res., 40: 4113–4122, 1980.
13. Fernandes, D. J., and Bertino, J. R. 5-Fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyuridylate binding to thymidylate synthetase by dihydropteroylpolyglutamates. Proc. Natl. Acad. Sci. U. S. A., 77: 5663–5667, 1980.
14. Fukushima, M., Ikenaka, K., Shirasaka, T., and Fujii, S. Metabolism of 5-fluorouracil in sensitive and resistant tumor cells. Gann, 70: 47–53, 1979.
15. Griswold, D. P., and Corbett. T. H. A colon tumor model for anticancer agent evaluation. Cancer (Phila.), 36: 2441–2444, 1975.
16. Hartmann, K.-U., and Heidelberger, C. Studies on fluorinated pyrimidines. XIII. Inhibition of thymidylate synthetase. J. Biol. Chem., 236: 3006–3013. 1961.
17. Heidelberger, C. Fluorinated pyrimidines and their nucleosides. In: A. C. Sartorelli and D. G. Johns (eds.). Handbook of Experimental Pharmacology, Vol. 38, Part 2, pp. 193–231. New York: Springer-Verlag, 1975.
18. Heidelberger, C., Kaldor, G., Mukherjee, K. L., and Danneberg, P. B. Studies on fluorinated pyrimidines. XI. In vitro studies on tumor resistance. Cancer Res., 20: 903–909, 1960.
19. Houghton, J. A., Maroda, S. J., Phillips, J. O., and Houghton, P. J. Biochemical determinants of responsiveness to 5-ftuorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice. Cancer Res., 41: 144–149, 1981.
20. Hurlbert, R. B., Schmitz, H., Brumm, A. F., and Potter. V. R. Nucleotide metabolism. II. Chromatographic separation of acid-soluble nucleotides. J. Biol. Chem., 209: 23–39, 1954.
21. Kessel, D., and Hall, T. C. Influence of ribose donors on the action of 5-fluorouracil. Cancer Res., 29: 1749–1754, 1969.
22. Kessel. D., Hall. T. C., and Wodinsky. I. Nucleotide formation as a determinant of 5-fluorouracil response in mouse leukemias. Science (Wash. D. C.), 154: 911–913, 1966.
23. Kisliuk, R. L., and Gaumont, Y. Polyglutamyl derivatives of folate as substrates and inhibitors of thymidylate synthetase. J. Biol. Chem., 249: 4100–4103. 1974.
24. Klubes, P., Connelly. K., Cerna, I., and Mandel, H. G. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5’-monophosphate and 2’-deoxyuridine 5’-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors. Cancer Res., 38: 2325–2331, 1978.
25. Langenbach, R. J., Danenberg, P. V., and Heidelberger, C. Thymidylate synthetase: mechanism of inhibition by 5-fluoro 2’-deoxyuridylate. Biochem. Biophys. Res. Commun., 48: 1565–1571, 1972.
26. Laskin, J. D., Evans, R. M., Slocum, H. K., Burke, D., and Hakala, M. T. Basis for natural variation in sensitivity to 5-fluorouracil in mouse and human cells in culture. Cancer Res., 39: 383–390, 1979.
27. Leslie, I. The nucleic acid content of tissues and cells. In: E. Chargaff and J. N. Davidson (eds.). The Nucleic Acids. Vol. 2, pp. 1–50. New York: Academic Press, Inc., 1955.
28. Lockshin, A., and Danenberg, P. V. Thymidylate synthetase and 2’-deox-yuridylate form a tight complex in the presence of pteroyltriglutamate. J. Biol. Chem., 254: 12285–12288, 1979.
29. Lockshin, A., and Danenberg, P. V. Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase. Biochem. Pharmacol., 30: 247–257, 1981.
30. Mandel, H. G., Klubes, P., and Fernandes, D. J. Understanding the actions of carcinostatic drugs to improve chemotherapy: 5-fluorouracil. Adv. Enzyme Regul., 16: 79–93, 1977.
31. Maybaum, J., Ullman, B., Mandel. H. G., Day, J. L., and Sadee, W. Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells. Cancer Res., 40: 4209–4215, 1980.
32. Moran, R. G., Domin, B. A., and Zakrewski, S. F. On the accumulation of polyglutamyl dihydrofolate in methotrexate (MTX) inhibited L1210 cells. Proc. Am. Assoc. Cancer Res., 16: 49, 1975.
33. Moran, R. G., Spears, C. P., and Heidelberger, C. Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2’-deoxyuridylate, 2’-deoxyuridylate, and thymidylate synthetase. Proc. Natl. Acad. Sci. U. S. A., 76: 1456–1460, 1979.
34. Moran, R. G., Werkheiser, W. C., and Zakrewski, S. F. Folate metabolism in mammalian cells in culture. I. Partial characterization of the folate derivatives present in LI210 mouse leukemia cells. J. Biol. Chem., 251: 3569–3575
35. Munro. H. N., and Fleck, A. The determination of nucleic acids. Methods Biochem. Anal., 14: 113–176, 1966.
36. Myers. C. E., Young, R. C., and Chabner, B. A. Biochemical determinants of 5-fluorouracil response in vivo. J. Clin. Invest., 56: 1231–1238, 1975.
37. Myers. C. E., Young, R. C., Johns, D. G., and Chabner, B. A. Assay of 5-ftuorodeoxyuridine 5’-monophosphate and deoxyuridine 5’-monophosphate pools following 5-fluorouracil. Cancer Res., 34: 2682–2688, 1974.
38. Navalgund, L. G., Rossana, C., Muench, A. J., and Johnson, L. F. Cell cycle regulation of thymidylate synthetase gene expression in cultured mouse fibroblasts. J. Biol. Chem., 255: 7386–7390, 1980.
39. Priest, D. G., Ledford, B. E., and Doig, M. T. Increased thymidylate synthetase in 5-fluorodeoxyuridine resistant cultured hepatoma cells. Biochem. Pharmacol., 29: 1549–1553, 1980.
40. Reyes, P., and Hall, T. C. Synthesis of 5-fluorouridine 5’-phosphate by a pyrimidine phosphoribosyltransferase of mammalian origin—II. Correlation between tumor levels of the enzyme and the 5-fluorouracil-promoted increase in survival of tumor-bearing mice. Biochem. Pharmacol., 18: 2587–2590, 1969.
41. Richards. G. M. Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal. Biochem., 57: 369–376, 1974.
42. Roberts, D. An isotopic assay for thymidylate synthetase. Biochemistry, 5: 3546–3548, 1966.
43. Santi, D. V., McHenry, C. S., and Sommer, H. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry, 13:471–481. 1974.
44. Schwartz, P. M., Dunigan, J. M., Marsh, J. C., and Handschumacher. R. E. Allopurinol modification of the toxicity and antitumor activity of 5-fluorouracil. Cancer Res., 40: 1885–1889, 1980.
45. Spiegelman, S., Sawyer, R., Nayak, R., Ritzi, E., Stolfi, R., and Martin. D. Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation. Proc. Natl. Acad. Sci. U. S. A., 77: 4966–4970, 1980.
46. Tyerman, M. J., Watson, J. E., Shane. B., Schutz, D. E., and Stockstad, E. R. L. Identification of glutamate chain lengths of endogenous folylpoly-y-glutamates in rat tissues. Biochim. Biophys. Acta, 497: 234–240. 1977.
47. Wahba, A. J., and Friedkin. M. The enzymatic synthesis of thymidylate. I., Early steps in the purification of thymidylate synthetase of Escherichia coli. J. Biol. Chem., 237: 3794–3801, 1961.
48. Washtien, W. L., and Santi, D. V. Assay, of intracellular free and macromo-lecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil. Cancer Res., 39: 3397–3404, 1979.
49. Wilkinson. D. S., and Crumley, J. Metabolism of 5-fluorouracil in sensitive and resistant Novikoff hepatoma cells. J. Biol. Chem., 252: 1051–1056, 1977.
50. Wilkinson, D. S., Solomonson, L. P., and Cory, J. G. Increased thymidylate synthetase activity in 5-fluorodeoxyuridine-resistant Novikoff hepatoma cells (39673). Proc. Soc. Exp. Biol. Med., 154: 368–371, 1977.